AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2015
Aug 13, 2015
34931_dirs_2015-08-13_b5664dd9-49be-4183-aa4b-e53b0c02fb35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2015-08-12
Reporting Person: VATERS ROBERT S (Director, President & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-12 | Common Stock, par value $0.001 per share | P | 12385 | $1.3469 | Acquired | 228750 | Direct |